Novartis to use Incyte's database:
This article was originally published in Clinica
Executive Summary
Novartis is to use Incyte's LifeSeq gene sequence and expression database for an undisclosed annual fee. Under the multi-year agreement, Incyte could also receive royalties on sales of products developed as a result of its technology and database information.